Free CME

ScientiaCME provides medical professionals with continuing medical education resources aimed at keeping physicians updated on the latest advances in medicine and filling the gaps in professional knowledge. 

ScientiaCME online CME resources are free and be quickly completed to earn CME credits. The programs cover many topics but have a focus on medical devices, lab monitoring, diagnostics, and pharmacotherapy.

The Doctor’s Channel offers free CME videos that can be viewed to earn CME credits. These short videos offer a quick and convenient way for physician to complete their CME requirements and learn about the latest news and ideas regarding a specific topic. 

Examples of topics covered by the Doctor’s Channel videos include allergies, bipolar disorder, infections, and risk management.

Platform Q is a leading free CME provider that offers live online medical education events that help physicians meet their CME requirements.

They have an extensive catalog of learning channels that cover multiple medical specialties. These channels are:

• CancerCoachLive
• CardioCareLive
• ClinicalSeriesLive
• DiabetesEyeHealth
• DiabetesSeriesLive
• IDCareLive
• ImmunologyLive
• NeuroCareLive
• NeuroSeriesLive
• ObesitySeriesLive
• OMedLive
• PainCareLive
• PsychiatryCareLive
• RareDiseaseLive
• RESInsightsLive
• UroCareLive
• VirtualProstate Summit

Scientia CME Immunology – Allergy CME has three selections:
• Chronic Urticaria (CU): Therapeutic Updates, Best Practices, and Barriers to Care (1 hr CME);
• Psoriasis: Best Practices, Barriers to Care, and Emerging Therapies (1 hr CME)
• Asthma and allergic asthma: personalizing treatment to the patient and therapeutic updates (1 hr CME)

Target Audience:
Physicians specializing in Allergy or Dermatology.

This free Rheumatology CME program contains 4 activities and offers 1.00 AMA PRA Category 1 Credits™

After completing this course, you will better be able to:

• Review the pathophysiology, as well as etiologic and risk factors, associated with the development of gout.
• Incorporate patient education and guidance into practice to improve adherence and compliance to prescribed therapeutic regimens.
• Apply the evidence and best practices when diagnosing gout in everyday practice.
• Use evidence-based guidelines and best practices when treating and monitoring hyperuricemia and gout.
• Apply recent clinical data relating to mechanisms, efficacy, and safety of conventional and new treatment options to improve the overall outcomes of patients with hyperuricemia and gout.

Advances in Treating Metastatic Colorectal Cancer (CRC) discusses the diagnosis and treatment of metastatic colorectal cancer (mCRC).

By the end of Advances in Treating Metastatic Colorectal Cancer (CRC), you will be better able to:
• Describe present the current practice guideline recommendations with respect to colorectal cancer screening, including colonoscopy preparation, and apply them to patient cases
• Identify the treatment modalities currently available for management of mCRC and apply them to patient cases using evidence-based medicine
• Evaluate a treatment plan for a specific patient with mCRC to optimize safety, efficacy, and tolerability, suggesting modifications for improvement
• Describe the challenges and barriers to care associated with treating patients with mCRC

In order to receive credit from ScientiaCME, you must first establish a username and password.

Target Audience:
Medical oncologists, primary care physicians, pathologists, gastroenterologists, and managed care medical care directors; physicians assistants, nurse practitioners, nurses, and pharmacists specializing in oncology; and other clinicians who are involved in providing diagnostic and therapeutic services for patients with CRC.

Carcinoid Syndrome: Updates in Pathophysiology, Diagnosis, and Treatment consists of a single lecture and discussion by Drs. Matthew H. Kulke and C. Metz.

After viewing Carcinoid Syndrome, you will be better able to:
• Summarize the cause of carcinoid syndrome
• Perform an appropriate workup and differential diagnosis from presenting symptoms
• Adopt evidence-based best practices in managing carcinoid syndrome, including strategies to address refractory or poorly controlled symptoms
• Evaluate safety and efficacy of current and emerging treatment approaches for carcinoid syndrome

Target Audiences:
This program is intended for US-based medical oncologists, endocrinologists and gastroenterologists, as well as oncology physician assistants, nurse practitioners, and nurses involved in the diagnosis and management of carcinoid tumors and carcinoid syndrome.

This free Neurology CME program features 2 activities and offers 0.50 AMA PRA Category 1 Credits™

Upon successful completion of this activity, participants should be better able to:

• Assess edaravone; its mechanisms of action, similarities, and differences from riluzole; and how to use it in clinical practice to reduce the progression of amyotrophic lateral sclerosis (ALS).
• Assess the use of multidisciplinary approaches and patient-centered decision making in the care of patients with ALS.

Inflammatory bowel disease (IBD) is a broad term that includes many different forms of inflammatory bowel conditions, the most common of which are Crohn’s Disease and ulcerative colitis, the former of which affects any area of the alimentary canal.

After reviewing Crohn’s Disease: Therapeutic Updates, Barriers to Care, and Emerging Therapies, you will be better able to:
• Describe the strengths and weaknesses of present and emerging diagnostic techniques, where applicable in Crohn’s disease.
• Describe strengths of different professional organizations’ guidance in Crohn’s disease diagnosis and treatment guidelines
• Describe emerging therapies in the treatment of Crohn’s disease.
• Describe barriers to care in the treatment of Crohn’s disease and suggest ways to ameliorate them.
• Identify the present treatment options currently available for management of Crohn’s disease and apply them to patient cases using evidence-based medicine.

Target Audience:
Healthcare professionals specializing in: gastroenterology, internal medicine, or those who otherwise commonly care for patients with Crohn’s disease.

This course contains two courses:
• Crohn’s Disease: Therapeutic Updates, Barriers to Care, and Emerging Therapies (1 hr CME)
• Inflammatory Bowel Disease (IBD): A Global Approach to Quality Management and Barriers to Care in an Era of Resource Consciousness(1.25 hr CME)

In order to get credit from ScientiaCME, you must first establish a username and password.

Target Audience:
Healthcare professionals specializing in colon and rectal surgery, family medicine, internal medicine, gastroenterology, oncology, pain management, palliative care, primary care, proctology, and other clinicians who treat patients suffering from gastrointestinal disorders.